We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

100 hedge funds and large institutions have $385M invested in Intra-Cellular Therapies Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more call options, than puts

Call options by funds: $6.76M | Put options by funds: $1.5M

21% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 29

15% less funds holding

Funds holding: 117 → 100 (-17)

19% less capital invested

Capital invested by funds: $476M → $385M (-$91.7M)

59% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 27

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
100
Holders Change
-17
Holders Change %
-14.53%
% of All Funds
2.49%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
35
Reduced
29
Closed
27
Calls
$6.76M
Puts
$1.5M
Net Calls
+$5.26M
Net Calls Change
+$3.75M

Top Buyers

1
Bank of America
Bank of America
North Carolina
+$10.7M
2
WA
Wasatch Advisors
Utah
+$7.59M
3
Citadel Advisors
Citadel Advisors
Florida
+$6.94M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$6.06M
5
Goldman Sachs
Goldman Sachs
New York
+$5.19M

Top Sellers

1
CCI
Columbus Circle Investors
-$6.19M
2
CCP
Clough Capital Partners
Massachusetts
-$6.05M
3
SCM
Sarissa Capital Management
Connecticut
-$5.85M
4
Millennium Management
Millennium Management
New York
-$5.73M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
126
US Bancorp
Minnesota
– -$2K -96 Closed
VCM
127
Versant Capital Management
Arizona
– -$220 -19 Closed
2 3 4 5
6